Location History:
- Lörrach, DE (2019)
- Loerrach, DE (2017 - 2022)
- Lorrach, DE (2022)
Company Filing History:
Years Active: 2017-2022
Title: Charis Papavassilis: Innovator in Psoriasis Treatment
Introduction
Charis Papavassilis is a notable inventor based in Loerrach, Germany. She has made significant contributions to the field of dermatology, particularly in the treatment of psoriasis. With a total of five patents to her name, her work focuses on innovative methods that improve patient outcomes.
Latest Patents
Among her latest patents, Charis has developed methods for treating psoriasis using IL-17 antagonists. This disclosure relates to novel regimens that employ a therapeutically effective amount of an IL-17 antagonist, such as an IL-17 binding molecule or an IL-17 antibody like secukinumab. Additionally, she has patented methods for treating palmoplantar pustular psoriasis (PPP) using IL-17 antibodies. These methods include treatment regimens, uses, kits, and therapies that utilize the administration of IL-17 antagonists. Furthermore, her patents disclose improved methods for treating plaque-type psoriasis, which involve up-titration and down-titration of the IL-17 antagonist, as well as modifications of dose frequency.
Career Highlights
Charis is currently employed at Novartis AG, where she continues to advance her research in psoriasis treatment. Her innovative approaches have garnered attention in the medical community, contributing to the development of effective therapies for patients suffering from this chronic skin condition.
Collaborations
Charis collaborates with esteemed colleagues, including Oliver Sander and Achim Guettner. Their combined expertise enhances the research and development of new treatment methodologies.
Conclusion
Charis Papavassilis stands out as a pioneering inventor in the field of psoriasis treatment. Her innovative patents and dedication to improving patient care highlight her significant impact on dermatological research.